Differential antioxidant properties of red wine in water soluble and lipid soluble peroxyl radical generating systems

被引:11
作者
Faustino, RS
Clark, TA
Sobrattee, S
Czubryl, MP
Pierce, GN
机构
[1] Univ Manitoba, Dept Physiol, St Boniface Gen Hosp, Res Ctr,Natl Ctr Agri Food Res Med, Winnipeg, MB R2H 2A6, Canada
[2] Univ Manitoba, Dept Physiol, St Boniface Gen Hosp, Res Ctr,Div Stroke & Vasc Dis, Winnipeg, MB R2H 2A6, Canada
基金
加拿大健康研究院;
关键词
atherosclerosis; heart disease; LDL oxidation; oxygen derived free radicals; vitamin E;
D O I
10.1023/B:MCBI.0000041862.89750.93
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Red wine and its components have been shown to possess cardioprotective and anti-atherogenic effects. Additionally, red wine and many of its components like catechin, epicatechin, rutin, transresveratrol and quercetin possess antioxidant properties. Oxidized low density lipoprotein (LDL) is involved in the development of an atherosclerotic lesion. Red wine, therefore, may be anti-atherogenic because of its antioxidant effects on LDL modification. This study examined the antioxidant effects of catechin, epicatechin, rutin, transresveratrol, quercetin and Merlot wines on LDL oxidation. Merlot was chosen because although other red wines have been tested, limited information exists for this variety. Oxidation was carried out with AAPH (2,2'-Azo-bis(2-amidinopropane) dihydrochloride) and AMVN (2,2'-Azo-bis(2,4-dimethylvaleronitrile)), as water and lipid soluble peroxyl radical generating systems (FRGS), respectively. This allowed us to determine the lipophilic antioxidant characteristics of the wine and its components. Conjugated diene assays were used to measure LDL oxidation over 6 hrs. In an AAPH system, all polyphenolic compounds except transresveratrol displayed an antioxidant effect. LDL oxidation by AAPH was also inhibited by aliquots of Merlot wine. No antioxidant effects were observed in an AMVN environment except for a mild antioxidant effect by quercetin. Surprisingly, incubation of LDL with Merlot wine strongly protected against oxidation by AMVN. In summary, the five phenolic compounds displayed antioxidant effects in a water soluble free radical generating system, but only quercetin showed this in a lipid soluble one. However, red wine inhibited LDL oxidation by both water and lipid soluble free radical generating systems. Our data suggest, therefore, that red wines contain unidentified antioxidants that provide protection against LDL oxidation within a lipid soluble environment.
引用
收藏
页码:211 / 215
页数:5
相关论文
共 27 条
[11]   Human monocytes/macrophages release TNF-alpha in response to Ox-LDL [J].
Jovinge, S ;
Ares, MPS ;
Kallin, B ;
Nilsson, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (12) :1573-1579
[12]   Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages [J].
Kusuhara, M ;
Chait, A ;
Cader, A ;
Berk, BC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :141-148
[13]   Antioxidant capacities and phenolics levels of French wines from different varieties and vintages [J].
Landrault, N ;
Poucheret, P ;
Ravel, P ;
Gasc, F ;
Cros, G ;
Teissedre, PL .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (07) :3341-3348
[14]  
LAVY A, 1993, EUR J CLIN CHEM CLIN, V31, P83
[15]   (+)-Catechin as antioxidant: mechanisms preventing human plasma oxidation and activity in red wines [J].
Lotito, SB ;
Fraga, CG .
BIOFACTORS, 1999, 10 (2-3) :125-130
[16]  
MAKRIS DP, 2001, J AGR FOOD CHEM, V49
[17]   The importance of lipid solubility in antioxidants and free radical generating systems for determining lipoprotein peroxidation [J].
Massaeli, H ;
Sobrattee, S ;
Pierce, GN .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (11-12) :1524-1530
[18]   Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice [J].
Miyagi, Y ;
Miwa, K ;
Inoue, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (12) :1627-&
[19]   THE RED WINE PHENOLICS TRANS-RESVERATROL AND QUERCETIN BLOCK HUMAN PLATELET-AGGREGATION AND EICOSANOID SYNTHESIS - IMPLICATIONS FOR PROTECTION AGAINST CORONARY HEART-DISEASE [J].
PACEASCIAK, CR ;
HAHN, S ;
DIAMANDIS, EP ;
SOLEAS, G ;
GOLDBERG, DM .
CLINICA CHIMICA ACTA, 1995, 235 (02) :207-219
[20]  
PENN MS, 1994, ATHEROSCLEROSIS, V108, P21